Fate Therapeutics (FATE) Retained Earnings (2012 - 2026)
Fate Therapeutics (FATE) reported Retained Earnings of -$77000.0 for Q1 2026, down 140.31% on a YoY basis from $191000.0 in Q1 2025, and down 166.38% quarter-over-quarter from $116000.0 in Q4 2025.
Fate Therapeutics (FATE) Retained Earnings (2012 - 2026) Analysis & Trends
Fate Therapeutics has reported Retained Earnings for 15 years, with the latest figure at -$77000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 140.31% year-over-year to -$77000.0; the trailing twelve-month figure through Mar 2026 stood at -$77000.0 (down 140.31% YoY), and the FY2025 full-year result was $116000.0, down 56.72% from the prior year.
- Retained Earnings for Q1 2026 stood at -$77000.0, down from $116000.0 in the prior quarter.
- The five-year high for Retained Earnings was $268000.0 in Q4 2024, with the low at -$1.5 billion in Q3 2025.
- Historically, Retained Earnings has averaged -$460.0 million across 5 years, with a median of -$2.8 million in 2022.
- The largest YoY upside for Retained Earnings was 1686.67% in 2024 against a maximum downside of 269607.62% in 2024.
- Fate Therapeutics' Retained Earnings stood at -$1.9 million in 2022, then soared by 100.81% to $15000.0 in 2023, then surged by 1686.67% to $268000.0 in 2024, then sank by 56.72% to $116000.0 in 2025, then slumped by 166.38% to -$77000.0 in 2026.
- The last three Retained Earnings figures came in at -$77000.0 (Q1 2026), $116000.0 (Q4 2025), and -$1.5 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | -1.50 Bn |
| Jun 30, 2025 | -1.47 Bn |
| Mar 31, 2025 | 191,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | -1.35 Bn |
| Jun 30, 2024 | -1.30 Bn |
| Mar 31, 2024 | -194,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | -499,000.00 |
| Jun 30, 2023 | -1.12 Bn |
| Mar 31, 2023 | -1.07 Bn |
| Dec 31, 2022 | -1.85 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | -3.38 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -769.08 Mn |
| Sep 30, 2021 | -700.46 Mn |
| Jun 30, 2021 | -86,000.00 |